Role of the nitric oxide/cyclic GMP/Ca2+ signaling pathway in the pyrogenic effect of interleukin-1β

被引:23
|
作者
Palmi, M [1 ]
Meini, A [1 ]
机构
[1] Univ Siena, Ist Sci Farmacol, I-53100 Siena, Italy
关键词
interleukin-1; beta; fever; intracellular Ca2+; nitric oxide; cyclic GMP; intracellular Ca2+ stores; human astrocytoma cells; rat striatum; neurotoxicity;
D O I
10.1385/MN:25:2:133
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Interleukin-1beta (IL-1beta) has a wide spectrum of inflammatory, metabolic, haemopoietic, and immunological properties. Because it produces fever when injected into animals and humans, it is considered an endogenous pyrogen. There is evidence to suggest that Ca2+ plays a critical role in the central mechanisms of thermoregulation, and in the intracellular signaling pathways controlling fever induced by IL-1beta and other pyrogens. Data from different labs indicate that Ca2+ and Na+ determine the temperature set point in the posterior hypothalamus (PH) of various mammals and that changes in Ca2+ and PGE(2) concentrations in the cerebrospinal fluid (CSF) of these animals are associated with IL-1beta-induced fever. Antipyretic drugs such as acetylsalicylic acid, dexamethasone, and lipocortin 5-(204-212) peptide counteract IL-1beta-induced fever and abolish changes in Ca2+ and PGE2 concentrations in CSF. In vitro studies have established that activation of the nitric oxide (NO)/cyclic GMP (cGMP) pathway is part of the signaling cascade transducing Ca2+ mobilization in response to IL-1beta and that the ryanodine (RY)- and inositol-(1,4,5)-trisphosphate (IP3)- sensitive pools are the main source of the mobilized Ca2+. It is concluded that the NO/cGMP/Ca2+ pathway is part of the signaling cascade subserving some of the multiple functions of IL-1beta.
引用
收藏
页码:133 / 147
页数:15
相关论文
共 50 条
  • [41] Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1
    Otero, M
    Lago, R
    Lago, F
    Reino, JJG
    Gualillo, O
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (03) : R581 - R591
  • [42] Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1
    Miguel Otero
    Rocío Lago
    Francisca Lago
    Juan Jesús Gomez Reino
    Oreste Gualillo
    Arthritis Research & Therapy, 7
  • [43] Cardiorespiratory responses to interleukin-1β in adult rats:: Role of nitric oxide, eicosanoids and glucocorticoids
    Graff, GR
    Gozal, D
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 1999, 107 (02) : 97 - 112
  • [44] Nitric oxide stimulates human sperm motility via activation of the cyclic GMP/protein kinase G signaling pathway
    Miraglia, Erica
    De Angelis, Federico
    Gazzano, Elena
    Hassanpour, Hossain
    Bertagna, Angela
    Aldieri, Elisabetta
    Revelli, Alberto
    Ghigo, Dario
    REPRODUCTION, 2011, 141 (01) : 47 - 54
  • [45] ROLE OF NITRIC-OXIDE CYCLIC-GMP SIGNALING MECHANISMS IN INCREASED PLATELET SENSITIVITY TO THROMBIN IN HYPERTENSION
    HUZOORAKBAR
    FASEB JOURNAL, 1995, 9 (04): : A922 - A922
  • [46] Acute application of interleukin-1β induces Ca2+ responses in human microglia
    Goghari, V
    Franciosi, S
    Kim, SU
    Lee, YB
    McLarnon, JG
    NEUROSCIENCE LETTERS, 2000, 281 (2-3) : 83 - 86
  • [47] Suppression of cyclic GMP-dependent protein kinase is essential to the Wnt/cGMP/Ca2+ pathway
    Ma, Li
    Wang, Hsien-yu
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (41) : 30990 - 31001
  • [48] Nitric oxide-cyclic GMP system potentiates glucose-induced rise in cytosolic Ca2+ concentration in rat pancreatic β-cells
    Matsuura, N
    Ishikawa, T
    Abe, S
    Yuyama, H
    Sugino, F
    Ishii, K
    Nakayama, K
    LIFE SCIENCES, 1999, 65 (14) : 1515 - 1522
  • [50] Alterations in nitric oxide/cyclic-GMP pathway in nondiabetic siblings of patients with type 2 diabetes
    Piatti, PM
    Monti, LD
    Zavaroni, I
    Valsecchi, G
    Van Phan, C
    Costa, S
    Conti, M
    Sandoli, EP
    Solerte, B
    Pozza, G
    Pontiroli, AE
    Reaven, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07): : 2416 - 2420